NCT05554471 - Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression | Biotech Hunter

Enrollment

352

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

July 11, 2023

Study Completion Date

July 11, 2023

Conditions

Venous Vascular Closure

Interventions

DEVICE

MYNX CONTROL™ Venous Vascular Closure Device 6F-12F

Mynx Control Venous VCD 6F-12F is indicated for use to seal femoral venous access sites while reducing times to hemostasis and ambulation.

Trial Locations (14)

NC Heart and Vascular Research, Raleigh

OnSite Clinical Solutions, Rock Hill

Baptist Health Miami Cardiac and Vascular Institute, Miami

Palm Vascular Centers, Miami Beach

Tampa Cardiovascular Interventions and Research, Tampa

Erlanger Health System, Chattanooga

Saint Luke's Hospital of Kansas City, Kansas City

Hightower Clinical, Oklahoma City

South Oklahoma Heart Research, Oklahoma City

North Dallas Research Associates, McKinney

Medical City Dallas Hospital, Dallas

Rio Grande Regional Hospital, McAllen

Colorado Heart and Vascular PC, Lakewood

Arizona Cardiovascular Research Center, Phoenix